Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy
about
Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytesGamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cellsGene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscleEpisodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channelsSarcospan-deficient mice maintain normal muscle functionMutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathyGenome-wide association study of anthropometric traits in Korcula Island, CroatiaMuscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophyExpression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complexSarcoglycan isoforms in skeletal muscleDefective assembly of sarcoglycan complex in patients with beta-sarcoglycan gene mutations. Study of aneural and innervated cultured myotubesAbsence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophySarcoglycan, the heart, and skeletal muscles: new treatment, old drug?Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complexDestabilization of the dystrophin-glycoprotein complex without functional deficits in alpha-dystrobrevin null muscleMG53 nucleates assembly of cell membrane repair machinery.Large-scale candidate gene analysis of HDL particle featuresDrosophila as a model for the identification of genes causing adult human heart disease.SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophyYoung MLP deficient mice show diastolic dysfunction before the onset of dilated cardiomyopathy.The dystrophin complex controls bk channel localization and muscle activity in Caenorhabditis elegans.Quantitative trait loci for exercise training responses in FVB/NJ and C57BL/6J mice.Ca2+ overload and mitochondrial permeability transition pore activation in living delta-sarcoglycan-deficient cardiomyocytes.Plasma membrane cytoskeleton of muscle: a fine structural analysis.Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.Equal force recovery in dysferlin-deficient and wild-type muscles following saponin exposure.Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L.The genetic basis of cardiac function: dissection by zebrafish (Danio rerio) screens.Increased neointimal thickening in dystrophin-deficient mdx mice.Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels.Does delta-sarcoglycan-associated autosomal-dominant cardiomyopathy exist?Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis.Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy.Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice.(-)-Epicatechin improves mitochondrial-related protein levels and ameliorates oxidative stress in dystrophic δ-sarcoglycan null mouse striated muscle.Molecular mechanisms of inherited cardiomyopathies.Molecular diagnosis of myocardial disease.Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy.Secondary coronary artery vasospasm promotes cardiomyopathy progression.
P2860
Q22253414-BCDE14E3-3277-43B3-8282-A11A2380BB38Q22253448-704DCE80-F700-4B16-BA1F-279E66CB220FQ24538577-10DC9939-C944-40E3-8521-9860AA00E852Q24553126-140E6D40-FE19-4F97-BBA9-C840912FD1BAQ24554300-6183178D-0E3B-4E4B-9B1C-68D89BC03917Q24604161-7037B7C3-D37E-4DC7-BC3A-F5C8007CCF6CQ24655879-8EA63001-6AEA-48F4-A7E9-E56526C97F06Q28083989-6DAC431D-1A92-49B6-BFB9-A95D22BA952FQ28138974-C3AAA61B-4023-41C3-957F-559C69AB8205Q28141128-96E7C332-D986-4227-B7D6-164F52DBD02AQ28203915-36119DC1-C6D2-40E9-B4BB-2DE28E6353DEQ28297222-050C2AA8-E68A-4A48-8DB5-EF0C3A80C0C3Q28346521-1B0CDD4D-07F1-48C4-B53C-37D8FAF6FD4EQ28346540-713326FA-437B-43FB-9FB1-6A766ACF9E27Q28473016-68A7168C-E8A7-4D61-AE20-19820EF62B88Q28511885-E468AE89-7A4C-4B8A-9424-3C5AC2F53659Q28743354-3045A93C-401B-4E64-9FEA-CB3B199D4E2FQ30476715-A47939D3-0928-45E7-9BA6-C83A9F546028Q30498086-A9355A7B-70A3-485D-806B-AE9DDB491321Q33217903-46BA082C-EA18-49DD-A6B4-3C4EB4CCEC31Q33519519-B1DF6798-A998-45DA-8142-7873A2AF92C0Q33593470-4F133C1A-3442-4680-BD38-AC49707F9ECCQ33622285-BD5575B3-3457-472C-88B8-90B979294FCBQ33840927-3D6F031C-2662-4C74-BE66-B98D98404E12Q33894636-4A306DD0-17BE-4AD6-A80D-44938821D949Q34028416-7A1C4E42-7E05-4ADA-8402-06E0078F6782Q34028619-E5933D7D-9B6B-49CA-BFA0-54C5BDB9796FQ34112808-820A4EA3-A5D8-410D-B83C-22812B041D03Q34125321-703A8D61-78A5-47EC-BDFF-C64C3F9CCDBBQ34278287-36A8B52E-CA80-454F-8A3B-C41176D263B1Q34327042-26089A9C-0BFB-4800-BDC6-D4E275CE3A8BQ34465820-3BC19A84-E0B8-4153-8DDE-24EA9C18ECDAQ34600310-FF177FA1-4519-46B1-A3A0-9ED43392E217Q34654773-79ACE56D-A05B-4CEB-8C67-8853DFA26991Q34674977-012E0454-8C8B-44C6-95AB-CA42F2CF51A7Q34882653-14CE34A1-432A-4331-B04D-E18D538D2D25Q35016608-4BA44FBA-6F18-4456-96AC-62A8B7AC7EC2Q35053205-778FD1BA-03CF-4017-91A0-0CEB24555CE0Q35088393-142A742F-1E1F-4B76-A6A3-C4687CBE4E50Q35096094-A1BD166A-460F-4E57-9D47-677DEA44894B
P2860
Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@ast
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@en
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@nl
type
label
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@ast
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@en
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@nl
prefLabel
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@ast
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@en
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@nl
P2093
P921
P3181
P1433
P1476
Disruption of the sarcoglycan- ...... yopathy and muscular dystrophy
@en
P2093
R Coral-Vazquez
R F Hrstka
R L Davisson
R Williamson
P304
P3181
P356
10.1016/S0092-8674(00)81975-3
P407
P577
1999-08-01T00:00:00Z